Additionally, He et al. demonstrated that CTSV knockdown synergistically enhanced the therapeutic efficacy of PD-1 inhibitors in HCC, suggesting a potential combinatorial approach for improving immunotherapeutic outcomes [46]. Here, CTSV is linked to hepatocellular carcinoma.